Patients Blueprints for UK pharma-NHS joint working Joint working could hold at least part of the answer to getting the NHS back on its feet after COVID, according to the ABPI.
Views & Analysis Tackling multimorbidity through collaboration As populations age, multimorbidity becomes an increasingly pertinent issue for healthcare systems.
Views & Analysis Sharing success to unlock the “triple win” of joint working The fortunes of the NHS and the UK’s life sciences industry are intertwined, with each sector’s success or failure heavily dependent on the other.
News New radiopharma Actithera emerges with $75.5m in financing A new player in radioligand therapies, Actithera, has arrived on the scene with $75.5m in funding and lead FAP-targeted candidate for cancer.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
